glp-1 cardiovascular outcomes trial august 2025 results Efficacy of GLP‐1 Receptor Agonist‐Based Therapies on Cardiovascular Events and Cardiometabolic Parameters in Obese Individuals Without Diabetes: A Meta‐Analysis of Randomized Controlled Trials Kidney and Cardiovascular Outcomes Among

[DOI] [PMC free article] [PubMed] [Google Scholar] 4.Do D., Lee T., Peasah S.K., Good C.B., Inneh A., Patel U

There was a whole Rick and Morty episode about having your body workout automatically while youre asleep (though that spiraled into the night versions trying to take over the day, but it's the same idea.) Today, telling newly diagnosed Type 2 Diabetics to exercise and lose weight rarely ever works (though that would reverse their condition in many cases) - so they start on Metformin, then more drugs, then diabetic foot needs to be surgically managed, wound cleaned, kidney problems, etc

However, it's essential to note that the use of GLP-1 for weight loss should be done under the supervision of a healthcare professional

Dunn SH, et al